Xie Jian 4

What Happened
Xie Jian, President and COO of Fulgent Genetics, sold 1,201 shares on May 27, 2026, in open‑market transactions for a total of approximately $21,138. The reported weighted‑average price was $17.60 per share; individual sale prices ranged from $17.39 to $17.76. This was a sale (not a purchase) made to satisfy tax withholding on vested restricted stock units.

Key Details

• Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (timely filing).
• Total shares sold: 1,201; weighted‑average price: $17.60; total value ≈ $21,138.
• Price range: $17.39–$17.76; reporting person can provide per‑trade details on request (footnote F2).
• Reason: Shares sold to satisfy tax withholding obligations from RSUs granted Feb 26, 2024 (footnote F1).
• Trust note: Some securities referenced are held by The Hsieh Family Dynasty Trust; Xie serves on its investment committee and disclaims beneficial interest except pecuniary (footnote F3).
• Transaction code: S = Sale.

Context
This was a routine sale to cover taxes on vested RSUs rather than a market-timed investment decision; such tax‑withholding sales are common and not necessarily a signal about the insider’s view of the company. The filing includes an undertaking to provide detailed per‑trade numbers and prices upon request.